Albireo


Also found in: Wikipedia.

Albireo

(al-beer -ee-oh) (β Cyg) A beautiful double star, the second brightest star in the constellation Cygnus. The primary is an orange giant with a deep blue companion 35″ away. mv : 3.1 (A), 5.1 (B); spectral type: K5 II (A), B8 V (B).
Mentioned in ?
References in periodicals archive ?
But I've always seen it as blue, from the first time I stumbled across it (looking for Albireo, of course), to this morning's predawn observing run.
The foot of the cross, or the beak of the swan, is marked by the modestly bright, 2nd-magnitude star Albireo (Beta Cygni).
28 November 2018 - US-based lower-middle-market private equity firm Huron Capital's building automation and energy services platform, Albireo Energy, has acquired energy management company Taylor Consulting and Contracting, the firm said.
Albireo Pharma announced the first patient has been enrolled in PEDFIC-1, a Phase 3 clinical trial of lead product candidate A4250, an ileal bile acid transporter inhibitor being studied for the treatment of patients with progressive familial intrahepatic cholestasis.
I "showed" them Albireo, the well-known double star in Cygnus, through the 12-inch refractor there.
Let's soar with Cygnus and visit some of the wonders scattered along his starry flyway, beginning with the beautiful double star Albireo in the Swan's beak.
13 October 2010 - Swedish biotechnology company Albireo yesterday reported encouraging top-line results from a Phase IIb study in chronic idiopathic constipation (CIC) assessing efficacy and safety of three different dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight-week trial.
M2 EQUITYBITES-December 21, 2018-LBC Credit serves as sole lead arranger for senior secured credit facilities to Albireo Energy
Other active ExecFactor platforms include Albireo Energy, Brudner Polymer Corp., Pure Dental Brands, Ronnoco Coffee, Valentus Specialty Chemicals and Sciens Building Solutions.
Albireo Pharma announced that data on a pharmacodynamic marker measured in its completed Phase 2 clinical trial evaluating lead product candidate A4250 in children with cholestatic liver disease and pruritus were presented during a poster session at the European Association for the Study of the Liver The International Liver Congress 2018 in Paris.
At the southwest end is 3rd-magnitude Beta ([beta]) or Albireo, a word not easily translated, though the star clearly establishes the head of our long-necked flyer.
The Swan's head is Albireo, or Beta (P) Cygni, one of the loveliest double stars in the heavens.